Health

Reuters exclusively reports EU regulator to decide on Pfizer booster dose at the start of October

Reuters exclusively reported that the European Medicines Agency expects to decide in early October on the possible use of a booster dose of the Pfizer-BioNTech, COVID-19 vaccine. It will be the EU drugs regulator’s first decision on boosters, after the U.S. Food and Drug Administration authorized a third dose of Pfizer for those 65 and older, all people at high risk of severe disease, and others who are regularly exposed to the virus.

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Europe
Countries: Belgium
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Important Regional Story
Sign up for email updates

Subscribe
Sign up for email updates